Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C479460
http://purl.bioontology.org/ontology/MESH/C479460
|
|---|---|
| Preferred Name | lixisenatide |
| Synonyms |
AVE-010
Lyxumia
AVE-0010
AVE 010
ZP10A peptide
AVE0010
ZP-10
AQVE-10010
DES-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-l-lysyl-l-lysinamide
ZP 10
Adlyxin
AVE 0010
See more
See less
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel |
AVE-010
Lyxumia
AVE-0010
AVE 010
ZP10A peptide
AVE0010
ZP-10
AQVE-10010
DES-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-l-lysyl-l-lysinamide
ZP 10
Adlyxin
AVE 0010
See more
See less
|
|---|---|
| prefLabel | lixisenatide
|
| II | D000067757
|
| Scope Statement | A synthetic GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1) agonist that binds GLP-1 receptor that is used to control blood sugar levels in patients with TYPE 2 DIABETES; amino acid sequence is H-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSK KKKKK-NH2 (ZP10A).
|
| type | |
| tui |
T116
T123
T121
|
| HM |
D000067758
D010455
|
| SC | 1
|
| TERMUI |
T000908879
T759901
T724131
T562103
T724133
T000908883
T000908881
T000908671
T000908880
T000908882
T000908884
T724132
T851434
See more
See less
|
| TH |
NLM (2009)
NLM (2008)
FDA SRS (2017)
USAN (19XX)
INN (19XX)
NLM (2003)
NLM (2017)
NLM (2014)
See more
See less
|
| SRC | J Pharmacol Exp Ther 2003 Nov;307(2);490-6
|
| MMR | 20230531
|
| notation | C479460
|
| Semantic type UMLS property | |
| cui |
C4307843
C4276110
C2973896
C3713829
C4307844
C2604519
C2973895
C1313707
See more
See less
|
| MeSH Frequency | 255
|
| PI | *CARRIER PROTEINS (2003-2010)
|
| LT | TRD
|
| DSC | 20031208
|
| Inverse of RB |
74O62BB01U
0
|
| Mapped to | |
| MDA | 20031208
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |